Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (566)
  2. Journal Article (461)
  3. Review (137)
  4. Editorial (61)
  5. Research Letter (44)
  6. Correspondence (14)
  7. Book Section (3)
  8. Guidelines (3)
  9. Conference Paper (2)
  10. Miscellaneous (2)
Groups
  1. Department of Medicine (1056)
  2. Graduate Medical Education (1000)
  3. GME, Medicine (979)
  4. Hematologic Malignancies, Division of (672)
  5. Weinberg Fellows (596)
  6. Solid Tumor Oncology Division (567)

More Groups

People
  1. Jan Bewersdorf (96)
  2. Zachary Epstein-Peterson (79)
  3. Sergio Giralt (78)
  4. Gunjan Shah (76)
  5. Marcel Van Den Brink (75)
  6. Michael Scordo (74)

More People

Years
  1. 2025 (85)
  2. 2024 (301)
  3. 2023 (296)
  4. 2022 (222)
  5. 2021 (159)
  6. 2020 (114)

More Years

Publications
  1. Blood (229)
  2. Journal of Clinical Oncology (203)
  3. Clinical Cancer Research (36)
  4. Cancer Research (35)
  5. Annals of Oncology (34)
  6. Journal of Thoracic Oncology (30)

More Publications

Publishers
  1. American Society of Hematology (262)
  2. American Society of Clinical Oncology (229)
  3. Elsevier Inc. (136)
  4. American Association for Cancer Research (101)
  5. Nature Publishing Group (98)
  6. Oxford University Press (58)

More Publishers

Results (1293)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selective intra-arterial mitomycin-C infusions for treatment-refractory colorectal liver metastases
    Journal Article

    Sotirchos, V. S.; Silk, M. T.; Camacho, J. C.; Schatoff, E. M.; Kunin, H. S.; Alexander, E. S.; Zhao, K.; Connell, L. C.; Sofocleous, C. T.; Kemeny, N. E.
    Journal of Gastrointestinal Oncology (2025)

    Fulltext@MSK | Save
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Goldman, A.; Tomas, A. A.; Fein, J. A.; Slingerland, J. B.; Parascondola, A.; Lin, R. J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate
    Journal Article

    Johannet, P.; Flint, M.; Chui, M. H.; Konner, J.; Friedman, C.; Green, A. K.; Guo, R.; Hensley, M. L.; Kyi, C.; Liu, Y.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL
    Research Letter

    Kittai, A. S.; Huang, Y.; Miller, S.; Allan, J. N.; Bhat, S. A.; Bond, D. A.; Brander, D. M.; Byrd, J. C.; Chavez, J. C.; Chong, E.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • High WEE1 expression is independently linked to poor survival in multiple myeloma
    Journal Article

    Simhal, A. K.; Firestone, R. S.; Oh, J. H.; Avutu, V.; Norton, L.; Hultcrantz, M.; Usmani, S. Z.; Maclachlan, K. H.; Deasy, J. O.
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Dynamics of immune reconstitution and impact on outcomes across CAR-T cell products in large B-cell lymphoma
    Journal Article

    Luan, D.; DeWolf, S.; Fei, T.; Raj, S.; Shah, G. L.; Lareau, C. A.; Alhomoud, M.; Salles, G.; Rivas-Delgado, A.; Rejeski, K.; more...
    Blood Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLL
    Review

    Soumerai, J. D.; Barrientos, J.; Ahn, I.; Coombs, C.; Gladstone, D.; Hoffman, M.; Kittai, A.; Jacobs, R.; Lipsky, A.; Patel, K.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: A multicenter real-world analysis
    Journal Article

    Pidala, J.; Kim, J.; Kalos, D.; Cutler, C.; DeFilipp, Z.; Flowers, M. E. D.; Hamilton, B. K.; Chin, K. K.; Rotta, M.; El Jurdi, N.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • BTK inhibitors versus venetoclax as first- or second-line therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world evidence study
    Research Letter

    Roeker, L. E.; Han, Y.; Teschemaker, A.; Mato, A. R.; Thompson, M. C.
    American Journal of Hematology (2025)

    Fulltext@MSK | Save